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Introduction. Restoration of upper extremity (UE) functional use remains a challenge for individuals following stroke. Repetitive
transcranial magnetic stimulation (rTMS) is a noninvasive modality that modulates cortical excitability and is being explored as
a means to potentially ameliorate these deficits. The purpose of this study was to evaluate, in the presence of chronic stroke, the
effects of low-frequency rTMS to the contralesional hemisphere as an adjuvant to functional task practice (FTP), to improve UE
functional ability.Methods. Twenty-two individuals with chronic stroke and subsequent moderate UE deficits were randomized to
receive 16 sessions (4 times/week for 4 weeks) of either real-rTMS or sham-rTMS followed by 1-hour of paretic UE FTP. Results.
No differences in UE outcomes were revealed between the real-rTMS and sham-rTMS intervention groups. After adjusting for
baseline differences, no differences were revealed in contralesional cortical excitability postintervention. In a secondary analysis,
data pooled across both groups revealed small, but statistically significant, improvements in UE behavioral measures. Conclusions.
rTMS did not augment changes in UE motor ability in this population of individuals with chronic stroke. The chronicity of our
participant cohort and their degree of UE motor impairment may have contributed to inability to produce marked effects using
rTMS.
1. Introduction
Between 55% and 75% of stroke survivors experience limita-
tions in functional use of the upper extremity at six-months
post-stroke [1]. Upper-limb motor recovery post-stroke is
of special concern because the impact of UE impairments
on disability and health is so marked [2, 3]. The persistence
of UE impairments and the resultant inability to use the
arm and hand prevents many individuals from returning
to work, representing significant socioeconomic impact on
the individual, the healthcare systems and society at large.
While these problems are well recognized, little progress has
been made in demonstrating substantive UE recovery in this
population.
Repetitive transcranial magnetic stimulation (rTMS) is
a form of noninvasive brain stimulation with the capacity
to modulate cortical excitability. In health, transcallosal
connections create an environment of mutual interhemi-
spheric inhibition [4], critical to normal motor control, and
especially relevant to performance of skilled movements.
Following stroke, decreased corticospinal excitability in the
lesioned hemisphere leads to an asymmetry in this mutual
transcallosal inhibition [5, 6]. Decreased ipsilesional cortical
excitability not only contributes directly to decreased drive to
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the corticospinal tract limiting activation of the contralateral
musculature, but also produces an imbalance between the
two hemispheres as inhibition to the contralesional hemi-
sphere is compromised [7]. Following stroke, the contrale-
sional M1 is argued to increase its inhibition acting on the
ipsilesional M1, further reducing ipsilesional M1 excitability.
During isolated voluntary movement of the paretic hand,
the contralesional motor cortex imposes an abnormally high
inhibitory drive onto the ipsilesional cortex [8] which may
contribute to paretic hand impairment [9]. Downregulation
of the contralesional hemisphere with a potential restoration
of mutual interhemispheric inhibition may contribute to
the restoration of paretic limb motor ability. Low-frequency
(e.g., ≤1 Hz) rTMS inhibits regional brain activity and may
increase contralateral cortical excitability via modulation of
interhemispheric inhibition. In healthy controls, with the
cerebral hemispheres functionally coupled and balanced,
application of low-frequency rTMS to one hemisphere results
in a decrease in the interhemispheric inhibition (IHI) from
the stimulated to the unstimulated hemisphere [10–12].
Two recentmeta-analyses concluded that rTMS produces
positive effects on finger motor ability and hand function fol-
lowing stroke [13, 14]. Although these simplemotor effects are
certainly encouraging, real-world functional UE use requires
engagement of the proximal shoulder and elbow to transport
the distal effector as it engages with the environment. The
purpose of this study was to evaluate, in the presence of
chronic stroke, the effects of low-frequency rTMS to the
contralesional hemisphere as an adjuvant to functional task
practice, on UE functional ability. In light of the importance
of functional, real world UE use we chose the Wolf Motor
FunctionTest (WMFT) as our primary outcome as it provides
an assessment of arm ability in its totality.
2. Material and Methods
2.1. Design. This double-blind randomized sham-controlled
trial examined the immediate and retention effects of rTMS
as an adjuvant to functional task practice of UEmotor ability.
2.2. Subjects. Participants were identified through a Uni-
versity of Florida Institutional Review Board (UF IRB-
01) approved registry at the Malcom Randall VA Brain
Rehabilitation and Research Center (BRRC). Individuals
who met the following inclusion criteria were invited to
participate: (1) stroke onset > 6 months prior, (2) passive
range of motion of paretic UE within functional limits,
(3) Upper Extremity Fugl-Meyer Motor (UEFM-M) [15]
assessment shoulder/elbow subcomponent score between 15–
25 and (4) 18–90 years of age. Potential participants were
excluded if they met any of the following criteria: (1) history
of epilepsy, brain tumor, learning disorder, intellectual or
developmental disabilities, drug or alcohol abuse, dementia,
major head trauma, ormajor psychiatric illness, (2) history or
radiographic evidence of arterio-venousmalformation, intra-
cortical hemorrhage, subarachnoid hemorrhage, or bilateral
cerebrovascular disease, (3) history of implanted pacemaker
or medication pump, metal plate in skull, or metal objects
in the eye or skull, (4) use of medications known to lower
seizure threshold, (5) pregnancy, (6) pain in paretic UE that
would interfere with movement, (7) inability to follow 3-
step instructions, (8) orthopedic condition in back or upper
extremity, (9) impaired corrected vision that would alter
kinematics of reaching, or (10) previous exposure to rTMS.
Individuals who met these criteria provided written, signed
Informed Consent approved by the UF IRB-01 prior to
enrollment. Participantswere randomly assigned to either the
experimental (EXP) group to receive real-rTMS or the con-
trol (CON) group to receive sham-rTMS. Randomizationwas
performed using a random number generator constrained to
produce an equal number of participants in each group.
2.3. Intervention. Each (𝑛 = 16; 4 times per week for 4 weeks)
intervention session consisted of low-frequency rTMS (real
or sham) to the contralesional hemisphere followed by 1-hour
of functional task practice activities, directed by a physical or
occupational therapist, aimed at improving motor ability of
the paretic arm and hand.
2.3.1. rTMS Intervention. rTMS was delivered using a
Magstim Rapid2 Stimulator (Magstim Company, Whitland,
UK) with an air-cooled figure-8 coil (70mm in diameter
per loop) over the contralesional M1, focused over the
optimal spot for stimulating the extensor carpi radialis (ECR)
muscle. The ECR is important in attaining hand position
for reach to grasp, and pointing to and touching objects in
the environment, all of which are foundational movements
for a functional upper extremity. First, the “hot spot,” the
optimal scalp position for consistently eliciting the largest
motor evoked potential (MEP) from the contralesional M1
representation corresponding to ECR, was determined. Next,
restingmotor threshold (rMT)was determined by decreasing
the stimulus intensity over the hot spot. rMT was defined as
the lowest stimulator output that elicited MEPs with a peak-
to-peak amplitude of 50 𝜇V in 6 of 10 trials [16]. The center
of the figure-8 coil was positioned tangentially over the “hot
spot,” and oriented perpendicular to the central sulcus for
optimal stimulation of the underlying tissue. A total of 1200
pulses were delivered as a single 1Hz train, at 100% of rMT,
established at each session. These stimulation parameters
have been used in previous studies [17–19] and fall within
the current recommended safety guidelines for rTMS [20].
Sham-rTMSwas delivered using a placebo coil that looks like
and imitates the sound of a real coil.
2.3.2. Functional Task Practice. Intervention was delivered
by a trained occupational or physical therapist, blinded to
participants’ group assignments. Session content was indi-
vidualized to participants’ interests, life roles, and level of
motor function. All tasks were functional in nature and
included reaching, grasping and/or manipulation of objects
performed with the paretic UE only. Specific tasks were then
chosen/designed by the interventionist for participants’ to
work at their challenge point. Examples of activities include
manipulation of coins, keyboarding, tossing/catching, trans-
porting items to/from various shelf heights, and opening
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closing drawers and doors. A detailed log of activities
performed (e.g., time on task, total number of repetitions,
repetitions/time) was recorded for each session to ensure
that participant was being progressed at each session. At
the subsequent session the interventionist would review
the previous session’s log to ensure progression of training
parameters.
2.4. OutcomeMeasures. All outcomemeasures were assessed
four times: pre-intervention baseline assessments were
repeated 1-week apart, after intervention and at 30-day reten-
tion. Standardized assessors, who were physical therapists
blinded to group assignment, conducted behavioral evalua-
tions. Neurophysiologic and kinesiologicmeasurements were
conducted by study investigators.
2.4.1. Clinical Measures. A clinical assessment battery eval-
uated participants across the domains of the World Health
Organization’s International Classification of Function, Dis-
ability, and Health [21]. The Wolf Motor Function Test
(WMFT) [22] was the primary behavioral outcome measure
of arm function.Othermeasures includedGrip, Lateral Pinch
(LP), Palmar Pinch (PP), and 3-Jaw Chuck (3JC) force [23],
UEFM-M [15] and the Action Research Arm Test (ARAT)
[24]. Light Touch (LT) sensation of the volar surface of
upper arm, palm, first digit and fifth digit was measured with
Semmes-Weinstein Monofilaments (North Coast Medical,
Morgan Hill, CA) [25]. The smallest monofilament sensed at
each locationwas recorded and given an ordinal score, using a
previously described scale [26].TheModifiedAshworth Scale
(MAS) [27] was used to assess muscle tone (composite score
of shoulder adductors and internal rotators, elbow flexors,
forearm pronators, wrist flexors, and finger flexors). The
Motor Activity Log (MAL) [28], a subjective assessment of
the amount of use (MAL-AOU) and how well the arm and
hand move (MAL-HW) in attempting real life tasks outside
of the laboratory environment and the Late-Life Functioning
Disability Index (LLFDI) [29], a comprehensive assessment
of functional limitations (altered ability to perform specific
actions encountered in daily routines) and disability (altered
performance of major life tasks and social roles) were admin-
istered.
2.4.2. Neurophysiologic Measures. Corticomotor excitability
of the contralesional hemisphere was assessed by determin-
ing: (1) rMT of the unaffected ECR, (2) 𝑉
50
, the stimulus
intensity at whichMEP amplitude is 50%of theMEPMAX, and
(3) short intracortical inhibition (SICI). Surface electromyo-
graphic signals were acquired using bipolar Ag-AgCL elec-
trodes applied in a belly-tendonmontage over the ipsilesional
ECR muscle. Signals were filtered between 1 and 1000Hz,
amplified, and digitized at a sampling rate of 2000Hz. Data
were acquired using a Powerlab16SP (AD Instruments, Grand
Junction, CO), and stored for later offline analysis using
LabChart Pro Software (Version 7.3.7). Single TMS pulses
were delivered using aMagstim 2002 stimulator with figure-8
coil.The coil was oriented perpendicular to the central sulcus
for optimal stimulation of the underlying motor cortex [30].
The “hotspot” corresponded to the stimulation site for which
the largest MEPs were obtained in the contralateral ECR.
rMT. Resting motor threshold was determined as the min-
imum stimulator intensity, expressed as a percentage of
maximum stimulator output (% MSO), capable of eliciting a
motor evoked response ≥50𝜇V in at least 5 of 10 consecutive
trials [16].
Recruitment Curves. Starting from rMT, stimulation intensity
(SI) was increased in increments of 5% (MSO) with five
stimuli applied at each SI until no further increase in MEP
amplitude was observed. Individual stimuli were delivered
in random intervals every 7–10 seconds to avoid stimulus
anticipation.
Short Intracortical Inhibition (SICI). SICI was measured by
paired-pulse (conditioned-test) stimulation with an inter-
stimulus interval of 3ms. SICI, a measure of inhibitory
intracortical activity, reflects GABAA-ergic activity in cortical
circuits [31, 32]. The test stimulus was delivered at the
SI that produced a resting MEP of ∼1mV peak to peak.
The conditioning stimulus was delivered at 70% of the test
stimulus. Single and paired stimulations (𝑛 = 5 each) were
delivered in random order. Responses within each condition
(i.e., paired, single) were averaged. SICI was expressed as
the ratio of conditioned MEP amplitude/test MEP amplitude
where values <1 reflect inhibition and >1 reflect facilitation.
2.4.3. Kinematics of Reaching. Participants were seated on a
backless bench with feet flat on the floor and hips, knees, and
ankles aligned at approximately 90 degrees of flexion. The
start position of the upper extremity was defined as hands,
palms side down, on the ipsilateral thigh with the shoulder
at approximately zero degrees of flexion. The target was a
40 mm sphere positioned 90% of arm’s length (measured
from acromion process to tip of index finger), aligned with
the reaching arm’s shoulder joint height and lateral location.
Participants were instructed to touch the target with their
index finger of the affected UE as fast as possible, in response
to a verbal “Go” signal. Participants practiced 1 to 2 trials prior
to recording to familiarize themselves with the task and the
instructions followed by 3 recorded trials.
Movements of the UE and trunk were captured by
tracking the three-dimensional position of 14mm reflective
markers using an eight-camera (T40; 4 megapixel resolution)
motion analysis system (Vicon Nexus 1.8.5 software, Oxford
Metrics Inc., Oxford, UK) at a sampling frequency of 200Hz.
Marker placement is based on a modified version of the
model described by Rab et al. and joint coordinate system
defined by Wu et al [33, 34]. The markers were affixed to
the following anatomical landmarks using double-sided tape:
seventh cervical and tenth thoracic vertebrae, suprasternal
notch, sternum body, sacrum, posterior superior iliac spine,
anterior superior iliac spine, acromion process, medial and
lateral epicondyles, styloid process of the radius and ulna,
lateral end of the second and fifth metacarpal bones and
distal phalange of the second digit. Stationary triads of
noncollinear 9mm reflective markers were affixed mid shaft
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to the upper and lower arms usingNylatex wraps and secured
with Mueller foam pre-wrap.
Data Reduction and Analysis. Marker data were labeled,
filtered (Butterworth, low-pass, 1st order, 10Hz, bidirec-
tional) and used to model (C-Motion, Visual3D software,
Germantown, MD) three-dimensional shoulder, elbow and
wrist joint angles. Additional analyses were performed using
custom MATLAB code (R2011b, MathWorks, Natick, MA).
Two events were manually identified using the Vicon Nexus
software: start and touch. Start was the time of movement
initiation and touch was the time when the index finger
reached the target. The metrics of interest for this study were
(1) movement time (MT), (2) maximum resultant velocity
(MRV), (3) trunk displacement (TD), (4) shoulder range of
motion (SROM), (5) elbow range of motion (EROM), and
(6) wrist range of motion (WROM). Movement time was
measured between the point where velocity surpassed 5% of
peak velocity and the point at which it fell below 5% of peak
velocity. Maximum resultant velocity was the point at which
velocity was the greatest. Trunk displacement in the anterior-
posterior direction during the reach task was measured with
the marker placed at T10. Shoulder, elbow, and wrist range
of motion are defined as the different the maximum and
minimum values each joint achieved from start to touch in
the flexion/extension direction.
Neurophysiologic data were analyzed using custom
MATLAB code (R2011b, Mathworks, Natik, MA, USA). EMG
data were filtered, demeaned, and rectified. MEPs at each SI
were averaged and the mean MEP area was calculated from
the averaged signal. MEP area at each SI was normalized
to MEP area at motor threshold. Recruitment curves were
constructed by plotting SI against MEP area followed by
fitting with a nonlinear equation (Boltzmann sigmoid) to
obtain the following parameters:
MEP (𝑠) = Bottom +
(Top − Bottom)
1 + exp ((𝑉
50
− 𝑥) /Slope)
, (1)
where 𝑠 represents SI, Top represents the peak height of the
recruitment curve, and 𝑉
50
represents the SI at which the
MEP amplitude is 50% of the MEPMAX [35, 36]. 𝑉50 was used
as the dependent variable to represent cortical excitability.
2.5. Statistical Analyses. Study sample size was determined
from previously published data on our primary outcome
measure, the Wolf Motor Function Test [37]. In that study of
224 poststroke individuals the average change on theWMFT
was 9.16 seconds. Anticipating a 50% greater improvement
in the contralesional rTMS + behavioral training than the
sham rTMS + behavioral training, a sample size of 10 in each
groupwas determined to provide 80% power with a𝑃 > 0.05.
Both time to complete andmovement quality of eachWMFT
task were assessed. The average time was computed for
all 15 tasks. Due to its skewed distribution (i.e., maximal
time = 120 seconds) WMFT-T scores were treated using the
natural logarithmic transformation to approximate a normal
distribution [37, 38]. Tabled logs were converted back to
seconds to aid interpretation. The Functional Assessment
Scale (WMFT-FAS), a 0–5 rating of movement quality (0 =
movement not attempted; 5 = movement appears normal)
was summed across the 15 items. Baseline health and demo-
graphic characteristics were summarized (by mean ± SE or
proportion) and compared across treatment groups using the
Kruskal-Wallis test (for continuous variables) or an exact chi-
square test (for categorical variables). The primary outcomes
were tested using the change scores from preintervention to
postintervention and from postintervention to the 1-month
retention assessment. Each outcome was summarized (by
mean ± SE) and compared between treatment groups (real-
rTMS versus sham-rTMS) using the Wilcoxon rank sum test
or two-sample 𝑡-test depending on the corresponding data
distribution. The signed rank test or paired 𝑡-test was used
for assessing the within-treatment change in each variable
and the overall change based on the pooled data from
both treatment groups. In addition, analysis of covariance
(ANCOVA) was used to assess adjusted treatment effects for
relevant variables controlling for baseline differences between
groups. All analyses were performed using SAS 9.3 (SAS
Institute Inc., Cary, NC).
3. Results
3.1. Recruitment. From three hundred twenty-five individu-
als screened 104 met eligibility criteria. The most common
reasons for exclusion were (1) comorbid medical conditions
(𝑛 = 98), (2) no overt motor deficit of the contralesional UE
(𝑛 = 56), and (3) excessive motor deficit of the contralesional
UE (𝑛 = 44). Eighty-two individuals were eligible but
declined to participate secondary to lack of transportation,
distance to study site, or time commitment required. Twenty-
two individuals were randomized (Figure 1).
3.2. Participant Flow and Characteristics of Participants. Of
the 22 subjects randomized, 1 withdrew prior to the start
of intervention, 1 withdrew during the intervention, and
1 withdrew following completion of the intervention but
prior to the 1-month retention assessment. No differences
were revealed in participants’ age, time post-stroke, stroke
location or race between the two groups (Table 1). An equal
number of males and females were represented in the sham-
rTMS group whereas the real-rTMS group had just one
female participant (see Table 1). No baseline differences were
revealed between groups in any of the clinical or kinesiologic
outcome variables. Baseline differences in SICI and 𝑉
50
were
detected. SICI was higher (49.6 versus 27.2; 𝑃 = 0.02) and
𝑉
50
was lower (43.4 versus 60.9; 𝑃 = 0.03) at baseline for the
real-rTMS compared to the sham-rTMS group.
3.3. Intervention and Subject Compliance. Ten of 11 partic-
ipants randomized to the real-rTMS group completed the
intervention. One participant in this cohort was unable to
return for the 1-month retention assessment. All 10 partic-
ipants randomized to the sham-rTMS group completed all
aspects of the study. There were no adverse events related to
the rTMS or the behavioral intervention.
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325 assessed for eligibility
10 allocated to sham-rTMS
Discontinued intervention Discontinued intervention
11 allocated to real-rTMS
Excluded
221 did not meet eligibility criteria
82 declined to participate
Lost to 1-month followup Lost to 1-month followup
AnalyzedAnalyzed
1 withdrew prior to intervention
Randomized (n = 22)
n = 1
n = 1
n = 0
n = 0
n = 9 n = 10
Figure 1: Flow of participants through the trial according to the CONSORT statement (rTMS, repetitive transcranial magnetic stimulation).
Table 1: Demographics of the study cohort.
Characteristic rTMS group(𝑛 = 9)
Sham group
(𝑛 = 10)
Mean age ± SD (y)
(range)
64.7 ± 7.0
(55–74)
64.6 ± 9.0
(49–77)
Mean time from stroke
onset ± SD (mo) (range)
60.4 ± 47.2
(9–146)
62.8 ± 51.7
(7–150)
Lesioned hemisphere 6 Left, 3 Right 4 Left, 6 Right
Sex 8 M, 1 F 5 M, 5 F
Race 9 W; 0 AA 9W; 1 AA
UEFM-M score 37.5 ± 7.0 40.7 ± 11.6
AA: African American; M: male; F: female; SD: standard deviation; y: years;
mo: months; UEFM-M: upper-extremity Fugl-Meyer motor.
3.4. Outcome Measures: Motor Impairment. No significant
differences were detected in either preintervention to postin-
tervention or postintervention to retention change scores
for any of the clinical measures across the ICF model
between the real-rTMS and sham-rTMS cohorts (Table 2).
Change scores were then pooled across both groups for each
of the clinical measures to determine whether significant
intervention-related changes could be detected with a larger
sample. For the entire cohort of participants, significant
changes from pre- to postintervention were detected in the
following variables: WMFT-T (−0.18 ± 0.09; 𝑃 = 0.05),
WMFT-FAS (2.3 ± 0.84; 𝑃 = 0.01), UEFM-M (4.2 ± 1.0; 𝑃 =
0.001), Grip force (1.4± 0.64;𝑃 = 0.04), ARAT (1.7± 0.73;𝑃 =
0.03), MAS (−1.8 ± 0.49; 𝑃 = 0.00), MAL-AOU (0.58 ± 0.18;
𝑃 = 0.00), and MAL-HW (0.62 ± 0.16; 𝑃 = 0.00) scales. No
significant changes were detected between postintervention
and retention for all outcome measures except for Grip force
(−1.26 ± 0.51; 𝑃 = 0.024) (Table 3).
3.5. OutcomeMeasures: Kinematic. No significant differences
in preintervention to postintervention or postintervention
to retention change scores were detected for any of the
kinematic variables measured during the reach to point task
between the real-rTMS and sham-rTMS cohorts (Table 2).
There were no differences in these measures when the data
were pooled across groups.
3.6. Outcome Measures: Neurophysiologic. Significant bet-
ween-group differences were detected in change scores for
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Table 3: Outcome measures for entire cohort (𝑛 = 20) from preintervention to postintervention and postintervention to retention.
Outcome measure Preintervention Postintervention Retention
Mean (SE) Mean (SE) Mean (SE)
WMFT-𝑇 (log performance time) 2.5 (0.27) 2.3 (0.27)∗ 2.3 (0.29)
WMFT-𝑇 (seconds) 12.2 (1.3) 10.0 (1.3)∗ 10.0 (1.3)
WMFT-FAS 46.2 (2.6) 48.5 (2.7)∗ 47.6 (2.7)
UEFM-M 39.1 (2.1) 43.3 (2.4)∗ 43.3 (2.4)
Grip force (kg) 14.0 (1.7) 15.4 (1.6)∗ 14.2 (1.7)∗
LP force (kg) 4.8 (0.43) 5.2 (0.44) 5.0 (0.48)
PP force (kg) 2.8 (0.37) 3.0 (0.41) 2.9 (0.40)
3JC force (kg) 3.0 (0.52) 3.4 (0.56) 3.4 (0.50)
ARAT 32.0 (2.9) 33.7 (2.7)∗ 33.7 (2.9)
Modified Ashworth Scale 5.3 (0.62) 3.5 (0.52)∗ 3.2 (0.55)
Light Touch 3.8 (0.63) 3.3 (0.67) 3.4 (0.51)
MAL-AOU 1.3 (0.21) 1.9 (0.23)∗ 1.8 (0.28)
MAL-HW 1.4 (0.22) 2.0 (0.24)∗ 1.8 (0.30)
LLFDI—function total 45.6 (1.5) 46.9 (1.5) 46.2 (1.9)
LLFDI—upper extremity 49.4 (2.0) 53.4 (2.1) 51.3 (2.6)
LLFDI—frequency dimension total 47.2 (1.7) 48.0 (1.9) 48.5 (2.4)
LLFDI—social role 44.4 (2.3) 45.5 (2.7) 46.2 (3.1)
LLFDI—personal role 48.2 (2.4) 50.2 (3.1) 50.9 (4.3)
LLFDI—limitation dimension total 57.9 (1.9) 60.8 (1.9) 60.6 (2.7)
LLFDI—instrumental role 54.8 (2.6) 58.9 (2.2) 58.3 (2.9)
LLFDI—management role 74.5 (2.6) 79.3 (3.2) 77.7 (3.7)
Movement time (sec) 1.2 (0.11) 1.1 (0.098) 1.1 (0.10)
Trunk displacement (mm) 49.3 (6.8) 46.3 (6.7) 47.1 (6.0)
Maximum resultant velocity (m/s) 0.99 (0.08) 1.1 (0.087) 1.1 (0.093)
Shoulder ROM (degrees) 41.2 (3.1) 39.3 (3.3) 41.5 (3.6)
Elbow ROM (degrees) 10.9 (1.5) 13.9 (2.1) 12.5 (2.1)
Wrist ROM (degrees) 9.3 (2.0) 11.3 (2.9) 8.1 (2.1)
SICI (% of test MEP) 38.4 (5.2) 23.6 (4.1)∗ 26.9 (3.6)
𝑉
50
(% MSO) 52.6 (4.2) 50.8 (3.1) 52.8 (4.0)
rMT (%MSO) 42.6 (3.3) 40.5 (4.4) 39.5
∗
𝑃 < 0.05.
SE: standard error; WMFT: Wolf Motor Function Test; FAS: Functional Assessment Scale; 𝑇: time; UEFM-M: upper extremity Fugl-Meyer motor; LP: lateral
pinch; PP: palmer pinch; 3JC: three jaw chuck; ARAT: Action Research Arm Test; MAL: Motor Activity Log; AOU: amount of use; HW: how well; LLFDI: Late
Life Function and Disability Index; ROM: range of motion; sec: seconds; mm: millimeters; m/s: meters per second; SICI: Short intracortical inhibition; MEP:
motor evoked potential; % MSO: percentage of maximum stimulator output; rMT: resting motor threshold.
contralesional hemisphere SICI (−29.22 ± 7.56 versus −0.33 ±
4.18; 𝑃 = 0.006) and 𝑉
50
(3.75 ± 2.89 versus −6.85 ± 3.51; 𝑃 =
0.034) from pre- to post-intervention (Figure 2). However,
after adjusting baseline differences in these two variables
between groups, no significant differences were detected for
changes in either contralesional SICI (𝑃 = 0.066) or 𝑉
50
(𝑃 = 0.344)
.
4. Discussion
This RCT evaluated the potential of low-frequency rTMS
applied to the contralesional hemisphere as an adjuvant to
functional task practice of the paretic UE to augment motor
recovery in persons chronic poststroke. We designed the
intervention dose (i.e., 1 hour session; 16 total sessions) to
align with that observed in clinical practice. Contrary to
our hypothesis we did not detect an augmentative effect of
contralesional low-frequency rTMS in chronic UE hemi-
paresis with this design and these intervention parameters.
In contrast 16 1-hour sessions of functional task practice
produced small improvements in outcome measures at the
impairment and functional limitation levels, regardless of
whether it was preceded by sham or real 1 Hz rTMS applied
over the hand area of contralesional M1. These results
corroborate those of others who have reported no additional
improvement in UE motor ability following stroke from
the application of contralesional rTMS [39–41]. Our results
point to a trend towards a decrease in the contralesional
hemisphere hyperexcitability as measured by SICI; however,
this change in cortical physiology did not correspond to
functional restoration of paretic UE motor ability. Although
contralesional hyperexcitability may contribute to UE motor
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Figure 2: No change in contralesional hemisphere SICI following
sham rTMS (open circle) in contrast to increased contralesional
SICI (greater inhibition) for the real inhibitory rTMS group.
(closed circle). Contralesional hemisphere SICI in the real rTMS
group was significantly reduced, suggesting a downregulation of
the preintervention hyperexcitable contralesional hemisphere. This
downregulation observed in the real rTMS group at posttest was not
retained at the 1-month retention assessment.
impairment, the lesioned hemisphere remains the primary
contributor to these deficits. Modulation of cortical excitabil-
ity may not be sufficient to contribute to paretic UE motor
ability in the presence of the primary lesion.
Administration of low-frequency rTMS for 20 minutes,
4 times/week followed by 1 hour of affected UE functional
task practice was both feasible and well-tolerated by all
participants with no adverse events from either aspect of the
intervention. Previous studies of contralesional rTMS have
examined effects following only a single bout of rTMS [19, 42–
46] or repeated bouts but fewer than the number studied here
[18, 39–41, 47]. The one study that administered a greater
number of sessions [48] did so within the confines of an
inpatient rehabilitation admission, easing participant burden.
Study participants were, on average, greater than 5 years
from stroke onset. Although most investigations of rTMS
enroll individuals greater than 6 months following stroke,
participants in this study exceeded the chronicity of other
stroke participant cohorts. It is possible that the interventions
employed in this study (both neurophysiological and behav-
ioral) were not able to induce change in individuals with the
degree of chronicity represented in this study.
For a new modality to be adopted into clinical practice,
a functional benefit must be observed. We purposely chose
a multijoint functional measure, the WMFT, as our primary
outcome measure to ascertain if functional changes in arm
ability that could be adopted into everyday life would result
from this combined intervention of low-frequency rTMS and
functional task practice. In contrast to other studies that
reported improvements in simple movements of the distal
aspects of the effector, low-frequency rTMS combined with
functional task practice did not improve functional, whole-
arm movements more than control sham-rTMS.
Effects on Contralesional M1 Cortical Excitability. Following
adjustments for baseline differences between the two groups
there were no differences in the changes in contralesional M1
cortical excitability following the intervention. These results
stand in contrast to previous studies that have reported
differences in cortical excitability following application of
contralesional low-frequency rTMS [44, 45]. However, a
recently conducted meta-analysis [13] of 8 studies reported
that changes of neurophysiologic measurements were not
significant, although the trend of these changes was positive,
as were ours. Our participants were more chronic poststroke
than participants in studies that have reported modulation
of cortical excitability following rTMS.The role of chronicity
in cortical excitability responsiveness to this modality is not
known and is an avenue of exploration that is needed.
Effects on UE Functional Ability. Despite positive and ex-
pected changes in SICI (e.g., reduced disinhibition) following
application of low-frequency rTMS, this postintervention
change was not associated with greater improvement in
paretic UE behavioral function for the experimental as
compared to the control group. However, when data from
both groups were pooled, small but statistically significant
improvements were revealed in measures of arm impairment
and function. Additionally these improvements were main-
tained for at least one month following the conclusion of
the intervention, even in the presence of chronic stroke. We
intentionally designed the time dedicated to the behavioral
intervention to mirror which is realistically available in
clinical practice. This limited amount of practice is probably
insufficient to produce transformative changes in chronic UE
functional limitations due to stroke.
5. Limitations
Analysis of baseline differences between groups revealed an
unanticipated difference in contralesional motor cortex SICI
between groups, precluding a straightforward between-group
comparison. Secondly, we powered this study based on pub-
lished data from the Extremity Constraint-Induced Therapy
Evaluation (EXCITE) clinical trial [37]. The EXCITE data
may not have been an appropriate reference as participants
in the trial presented here were more chronic and received
a smaller dose of behavioral intervention than EXCITE
participants. Although there was a positive behavioral effect
for the entire cohort, wemayhave been overoptimistic for this
small, preliminary trial to detect group differences.
6. Conclusions
Although the contralesional hemisphere revealed somewhat
greater intracortical inhibition following the intervention,
changes in this variable alone were not sufficient to affect
larger joint functional UE movements. Disinhibition of the
contralesional cortex is one factor contributing to impaired
UE motor ability following stroke. The primary stroke insult
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and the resultant decreased descending drive to theUEmotor
neuronal pools are not directly remediated by contralesional
low-frequency rTMS and thus may be greater contributors
to limb paresis. Although interhemispheric balance may be
reestablished through downregulation of the hyperexcitable
contralesional hemisphere by rTMS, further examination of
its role in addressing poststroke UE impairment is needed.
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